英语短文

健康短文 | 情商短文 | 生活短文 | 保健短文 | 家庭短文 | 健身短文 | 文化短文 | 市场营销 | 爱情短文 | 生活窍门

痤疮粉刺 癌症预防 糖尿病 药品短文 怀孕妊娠 性福生活 情绪管理 肺癌肺炎 脱发短文 心脏病 骨质疏松

New drug gives sight loss hope to thousands

kira86 于2011-07-27发布 l 已有人浏览
增大字体 减小字体
A new drug has reversed sight loss in sufferers of an eye condition passed down through families, gi

pills.jpg

A new drug has reversed sight loss in sufferers of an eye condition passed down through families, giving hope to thousands that they could be spared blindness.

A clinical trial has found that a quarter of patients who took idebenone for 24 weeks enjoying such improved vision that they were able to read an entire row of letters on a standard chart.

British researchers say it is the first evidence of a treatment that can reverse the effects of a mitochondrial disorder, affecting the energy factories of the eye’s cells.

The drug, manufactured by Santhera Pharmaceuticals, will now be assessed by European regulators before it can be offered to more patients.

Prof Patrick Chinnery of Newcastle University, which led the trial, said: “This is the first proven treatment for a mitochondrial disorder. We have seen patients who couldn’t even see an eye chart on the wall go on to read the first line down – and some even attempted the second line. For these patients, it can mean a vast improvement in their quality of life.

“While we know that their vision is not what it once was, we also know that this treatment can dramatically improve their lives – some were able to move around more easily or even see family photos again.”

In a paper published in the journal Brain, he and colleagues describe how they recruited 62 patients suffering from Leber’s Hereditary Optic Neuropathy (LHON), an inherited condition that can see people with normal vision lose the sight in one eye then the other within six months.

It is among the most common causes of inherited blindness and affects about 2,000 people in Britain.

In the trial, patients were either given the new drug or a placebo for 24 weeks, after which time several taking idebenone, marketed as Catena, were found to have greatly improved eyesight.

Nine of the 36 patients taking the drug were able to read at least one row of letters on a chart, while none of the 26 on the placebo showed the same improvement.

Those who had better vision in one eye than the other, likely to be at an earlier stage of the condition, showed the greatest improvement.

The drug works by penetrating the mitochondria in the eyes and “mopping up” toxic molecules that damage tissue.

 

 1 2 下一页

相关英语学习内容medicinesight lossscience

本文评论
您还能输入300

更多>>保健短文最新更新

更多>>Medecine最新更新

更多>>英语短文最新推荐

英语短文阅读排行